HomeInsightsStock Comparison

Ambalal Sarabhai Enterprises Ltd vs Astonea Labs Ltd Stock Comparison

Ambalal Sarabhai Enterprises Ltd vs Astonea Labs Ltd Stock Comparison

Last Updated on: Jun 15, 2025

Key Highlights

  • The Latest Trading Price of Ambalal Sarabhai Enterprises Ltd is ₹ 36.36 as of 13 Jun 15:30.
  • The P/E Ratio of Ambalal Sarabhai Enterprises Ltd changed from 10.4 on March 2020 to 61.5 on March 2024 . This represents a CAGR of 42.68% over 5 yearsThe P/E Ratio of Astonea Labs Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Ambalal Sarabhai Enterprises Ltd changed from ₹ 145.99 crore on March 2020 to ₹ 348.53 crore on March 2024 . This represents a CAGR of 19.01% over 5 yearsThe Market Cap of Astonea Labs Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Ambalal Sarabhai Enterprises Ltd for the Mar '25 is ₹ 66.45 crore as compare to the Dec '24 revenue of ₹ 51.73 crore. This represent the growth of 28.46% The revenue of Astonea Labs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Ambalal Sarabhai Enterprises Ltd for the Mar '25 is ₹ -0.07 crore as compare to the Dec '24 ebitda of ₹ 5.06 crore. This represent the decline of -101% The ebitda of Astonea Labs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Ambalal Sarabhai Enterprises Ltd changed from ₹ -4.87 crore to ₹ -0.27 crore over 8 quarters. This represents a CAGR of -76.45% The net profit of Astonea Labs Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Ambalal Sarabhai Enterprises Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Astonea Labs Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Ambalal Sarabhai Enterprises Ltd

  • Ambalal Sarabhai Enterprises Ltd., incorporated on June 5, 1978, houses a range of companies across multi-dimensional businesses.
  • Each subsidiary is a distinct entity contributing its unique expertise and capabilities.
  • It is one of the oldest pharmaceutical health care companies in India, and today through its group companies it manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and internationally.
  • ASE's strength is to lead with cutting edge technology by creating strategic technology tie-ups and collaborative partnerships through our broad national and international networks The Company produces a range of bulk drugs, pharmaceutical preparations and electronic instruments.
  • It operates in two segments, pharmaceuticals and electronics.

About Astonea Labs Ltd

  • Astonea Labs Ltd was originally incorporated as 'AHU Laboratories Private Limited', as a private limited company, pursuant to certificate of incorporation dated April 11, 2017.
  • Company changed its name from AHU Laboratories Limited to 'Astonea Labs Private Limited' dated February 26, 2019.
  • Subsequently, the Company converted into 'Astonea Labs Limited', vide fresh Certificate of Incorporation dated January 11, 2024. Company specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products.
  • These include antibiotic drugs, anticold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynecological concerns, analgesics, fungal infections, and multivitamins.
  • These are used for skin, tooth, and hair care, available in various forms such as gels, ointments, creams, lotions, oils, and serums.

Ambalal Sarabhai Enterprises Ltd News Hub

News

Ambalal Sarabhai Enterprises schedules AGM

Ambalal Sarabhai Enterprises announced that the 47th Annual General Meeting(AGM) of the co...

Read more

07 Jun 2025 09:30

News

Ambalal Sarabhai Enterprises to table results

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company ...

Read more

23 May 2025 17:45

News

Ambalal Sarabhai Enterprises to convene board meeting

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company ...

Read more

06 Feb 2025 11:55

News

Ambalal Sarabhai Enterprises to convene board meeting

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company ...

Read more

05 Nov 2024 13:38

News

Ambalal Sarabhai Enterprises announces board meeting date

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company ...

Read more

03 Aug 2024 10:31

News

Ambalal Sarabhai Enterprises to conduct AGM

Ambalal Sarabhai Enterprises announced that the 46th Annual General Meeting (AGM) of the c...

Read more

29 May 2024 15:01

Astonea Labs Ltd News Hub

News

BSE SME Astonea Labs inches higher on debut

The scrip was listed at Rs 137.45, a premium of 1.81% compared with the initial public off...

Read more

03 Jun 2025 11:01

SWOT Analysis Of Ambalal Sarabhai Enterprises Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Ambalal Sarabhai Enterprises Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Ambalal Sarabhai Enterprises Ltd and null

Which company has a larger market capitalization, Ambalal Sarabhai Enterprises Ltd or Astonea Labs Ltd?

Market cap of Ambalal Sarabhai Enterprises Ltd is 278 Cr while Market cap of Astonea Labs Ltd is 148 Cr

What are the key factors driving the stock performance of Ambalal Sarabhai Enterprises Ltd and Astonea Labs Ltd?

The stock performance of Ambalal Sarabhai Enterprises Ltd and Astonea Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ambalal Sarabhai Enterprises Ltd and Astonea Labs Ltd?

As of June 15, 2025, the Ambalal Sarabhai Enterprises Ltd stock price is INR ₹36.36. On the other hand, Astonea Labs Ltd stock price is INR ₹141.25.

How do dividend payouts of Ambalal Sarabhai Enterprises Ltd and Astonea Labs Ltd compare?

To compare the dividend payouts of Ambalal Sarabhai Enterprises Ltd and Astonea Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions